Morning Market Losers
Peregrine Pharmaceuticals (NASDAQ: PPHM) fell 74.58% to $1.37 at 10:55 am. Peregrine Pharmaceuticals reported that it discovered major discrepancies in its Phase II trial data of bavituximab.
Questcor Pharmaceuticals (NASDAQ: QCOR) shares dipped 31.50% to $20.64. Analysts at ThinkEquity downgraded Questcor from “buy” to “hold.”
Daegis (NASDAQ: DAEG) dropped 19.08% to $1.40. Daegis' trailing-twelve-month ROE is -110.48%.
Dialogic (NASDAQ: DLGC) shares lost 19% to $2.60. Dialogic shares have dipped 72.56% over the past 52 weeks, while the S&P 500 index has gained 25.57% in the same period.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.